• milestone alert: can-fite completes enrollment in phase 3 trial of oral piclidenoson for psoriasis The Dermatology Digest Mon, 06 Jul 2026 15:08:34 GMT
• Why is Can-Fite BioPharma stock climbing today? By Investing.com Investing.com Australia Mon, 06 Jul 2026 12:43:27 GMT
• Can-Fite BioPharma (CANF) Completes Patient Enrollment for Psori GuruFocus Mon, 06 Jul 2026 11:44:16 GMT
• Can-Fite (NYSE American: CANF) reaches key Phase 3 psoriasis interim analysis milestone Stock Titan Mon, 06 Jul 2026 11:03:38 GMT
• Can-Fite Achieves Key Pivotal Phase 3 Psoriasis Milestone GlobeNewswire Mon, 06 Jul 2026 11:00:00 GMT
• Can-Fite’s psoriasis study reaches interim analysis after 247 patients enrolled Stock Titan Mon, 06 Jul 2026 11:00:00 GMT
• Enterprise value to EBITDA forward of Can-Fite BioPharma Ltd. – TASE:CANF TradingView Sun, 05 Jul 2026 12:10:11 GMT
• Can-Fite’s Namodenoson meets primary safety endpoints in Phase IIa trial Clinical Trials Arena Fri, 03 Jul 2026 06:16:46 GMT
• Can-Fite Biopharma (CANF) Slumps 15.55% as Key Support Level Approaches - Inverse ETF Flow dars.gov.et Fri, 03 Jul 2026 02:41:31 GMT
• CANF Reiterated by HC Wainwright & Co. -- Price Target Raised to $8 GuruFocus Thu, 02 Jul 2026 13:11:56 GMT
• H.C. Wainwright Maintains Can-Fite BioPharma(CANF.US) With Buy Rating, Raises Target Price to $8 Moomoo Thu, 02 Jul 2026 13:06:29 GMT
• H.C. Wainwright raises Can-Fite BioPharma price target to $8 on trial data Investing.com Thu, 02 Jul 2026 11:40:30 GMT
• Can-Fite Biopharma Price Target Raised to $8.00/Share From $5.00 by HC Wainwright & Co. Moomoo Thu, 02 Jul 2026 11:09:00 GMT
• Can-Fite Highlights Survival Outcomes In Pancreatic Cancer Patients Sahm Thu, 02 Jul 2026 10:28:08 GMT
• can-fite’s namodenoson meets primary safety endpoints in phase iia trial Clinical Trials Arena Thu, 02 Jul 2026 08:41:24 GMT
• can-fite shares surge after pancreatic cancer study showed durable survival outcomes marketscreener.com Wed, 01 Jul 2026 17:12:12 GMT
• 12 Health Care Stocks Moving In Wednesday's Intraday Session Benzinga Wed, 01 Jul 2026 17:05:48 GMT
• can-fite posts positive mid-stage data for oral drug in pancreatic cancer FirstWord Pharma Wed, 01 Jul 2026 14:47:34 GMT
• Can-Fite BioPharma (CANF) Stock Soars 65% Following Positive Pancreatic Cancer Trial Results Blockonomi Wed, 01 Jul 2026 14:32:11 GMT
• Can-Fite Highlights Survival Outcomes In Pancreatic Cancer Patients Benzinga Wed, 01 Jul 2026 14:13:06 GMT
• CANF Stock Pops As Japan Patent Fuels Obesity-Drug Hype StocksToTrade Wed, 01 Jul 2026 14:04:00 GMT
• CANF Stock Jumps As Japan Patent Fuels Obesity Drug Hopes timothysykes.com Wed, 01 Jul 2026 13:18:00 GMT
• Can-Fite BioPharma (CANF) Reports Positive Results in Namodenoso GuruFocus Wed, 01 Jul 2026 12:08:58 GMT
• 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Benzinga Wed, 01 Jul 2026 12:05:43 GMT
• can-fite biopharma announces namodenoson study meets primary safety endpoint TipRanks Wed, 01 Jul 2026 11:43:36 GMT
• Can-Fite Phase 2a Pancreatic Cancer Study with Namodenoson Achieves Primary Safety Endpoint and Demonstrates Durable Survival Outc... The Manila Times Wed, 01 Jul 2026 11:04:27 GMT
• Namodenoson shows survival signal in Can-Fite (NYSE: CANF) Phase 2a Stock Titan Wed, 01 Jul 2026 11:02:43 GMT
• Can-Fite pancreatic cancer study shows survival beyond 5 months Stock Titan Wed, 01 Jul 2026 11:00:00 GMT
• Can Fite Biopharma stock surges 65% on pancreatic cancer data Investing.com Wed, 01 Jul 2026 07:00:00 GMT
• Can Fite Biopharma Ltd (CANF) Earnings Forecast: Future EPS & Revenue Growth Estimates TradingKey Wed, 01 Jul 2026 07:00:00 GMT
• can-fite biopharma ltd. sponsored adr financial disclosures & sec filings TradingView Tue, 30 Jun 2026 22:14:28 GMT
• When Will Can-Fite BioPharma Ltd. (TLV:CANF) Become Profitable? simplywall.st Tue, 30 Jun 2026 04:53:28 GMT
• CANF stock pulls back after patent-fueled surge – retail calls it consolidation ahead of next leg up MSN Mon, 29 Jun 2026 03:19:18 GMT
• price to book forward of can-fite biopharma ltd. – tase:canf TradingView Mon, 29 Jun 2026 01:40:55 GMT
• enterprise value to ebit forward of can-fite biopharma ltd. – tase:canf TradingView Sun, 28 Jun 2026 21:14:34 GMT
• CANF Slides On Heavy Volatility As Traders Probe Support StocksToTrade Sun, 28 Jun 2026 07:00:00 GMT
• can-fite biopharma secures japanese patent for a3 adenosine receptor agonists TipRanks Sat, 27 Jun 2026 18:18:57 GMT
• canf slides as traders weigh weak biotech financials timothysykes.com Sat, 27 Jun 2026 15:08:00 GMT
• canf slides after sharp intraday reversal tests support StocksToTrade Sat, 27 Jun 2026 12:38:00 GMT
• can-fite biopharma secures japanese patent for a3 adenosine receptor agonists TipRanks Fri, 26 Jun 2026 19:54:19 GMT
• can-fite biopharma (canf) secures key patent for fat loss treatm GuruFocus Fri, 26 Jun 2026 14:59:11 GMT
• CANF Stock Pulls Back After Patent-Fueled Surge – Retail Calls It Consolidation Ahead Of Next Leg Up Stocktwits Fri, 26 Jun 2026 14:46:14 GMT
• can-fite biopharma (nyseamerican:canf) jumps after japan patent update TechStock² Fri, 26 Jun 2026 13:06:00 GMT
• can-fite biopharma wins japanese patent for namodenoson’s anti-obesity technology TipRanks Fri, 26 Jun 2026 11:38:21 GMT
• Can-Fite BioPharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16] Moomoo Fri, 26 Jun 2026 11:10:28 GMT
• Can-Fite Secures Japanese Patent Allowance for Namodenoson's Anti-Obesity Technology GlobeNewswire Fri, 26 Jun 2026 11:00:00 GMT
• Can-Fite BioPharma Ltd. Sponsored ADR Actuals & Estimates (AMEX:CANF) TradingView Fri, 26 Jun 2026 08:42:29 GMT
• Can Fite Biopharma stock jumps on Japan patent for obesity drug Investing.com Fri, 26 Jun 2026 07:00:00 GMT
• Can-Fite wins Japan patent allowance for its obesity drug Namodenoson Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• Japan backs Can-Fite (NYSE: CANF) Namodenoson obesity patent expansion Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• CANF Stock Draws Trader Focus As Volatility Picks Up timothysykes.com Fri, 26 Jun 2026 07:00:00 GMT
• can fite biopharma ltd (canf) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• can fite biopharma ltd (canf) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• can-fite publishes peer-reviewed scientific article demonstrating the broad therapeutic potential of piclidenoson and namodenoson Sahm Tue, 23 Jun 2026 08:17:13 GMT
• can-fite biopharma publishes peer-reviewed scientific article demonstrating broad therapeutic potential of piclidenoson and namode... marketscreener.com Mon, 22 Jun 2026 15:46:24 GMT
• can-fite biopharma showcases broad potential of a3ar drug platform in new peer-reviewed study TipRanks Mon, 22 Jun 2026 11:31:00 GMT
• Form 6K Can-Fite BioPharma Ltd. For: 22 June By Investing.com Investing.com Canada Mon, 22 Jun 2026 11:17:47 GMT
• can-fite’s ‘master switch’ drugs: a biotech’s bet on a multi-disease cure BriefGlance Mon, 22 Jun 2026 11:00:00 GMT
• Can-Fite (NYSE: CANF) touts peer-reviewed A3AR data and late-stage pipeline Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Can-Fite review cites cancer, liver and brain data for two drugs Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• can fite biopharma ltd (canf) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 15:50:10 GMT
• can fite biopharma ltd (canf) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 00:03:14 GMT
• can fite biopharma ltd (canf) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 22:16:46 GMT
• can fite biopharma ltd (canf) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 21:37:40 GMT
• can fite biopharma ltd (canf) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 21:30:57 GMT
• can fite biopharma ltd (canf) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 21:21:41 GMT
• can fite biopharma ltd (canf) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 21:20:28 GMT
• can fite biopharma ltd (canf) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 16:53:03 GMT
• can-fite biopharma (canf) edges higher, testing key resistance at $3.22 - value factor newsline.com Wed, 17 Jun 2026 16:34:24 GMT
• can-fite biopharma to showcase late-stage pipeline and licensing deals at bio 2026 TipRanks Wed, 17 Jun 2026 11:51:09 GMT
• can-fite's high-stakes hunt: from lab innovation to global partnerships BriefGlance Wed, 17 Jun 2026 11:00:00 GMT
• Can-Fite to Present Late-Stage Clinical Pipeline and Licensing Opportunities at BIO International Convention 2026 GlobeNewswire Wed, 17 Jun 2026 07:00:00 GMT
• Can-Fite (NYSE: CANF) highlights late-stage cancer and liver drugs at BIO 2026 Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• can-fite biopharma presents late-stage clinical pipeline and licensing opportunities at bio international convention 2026 marketscreener.com Wed, 17 Jun 2026 07:00:00 GMT
• can fite biopharma ltd (canf) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• can-fite's high-stakes hunt: from lab innovation to global partnerships BriefGlance Tue, 16 Jun 2026 23:01:01 GMT
• can fite biopharma ltd (canf) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• can fite biopharma ltd (canf) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• canf q4 2023 earnings: narrower-than-expected loss drives positive stock reaction - eps miss report newsline.com Tue, 16 Jun 2026 02:42:23 GMT
• canf q4 2023 earnings: narrower-than-expected loss surprises, yet stock slips - buyback announcement report newsline.com Thu, 11 Jun 2026 07:48:10 GMT
• canf q4 2023 earnings: significant eps beat driven by lower losses - eps growth rate newsline.com Tue, 09 Jun 2026 22:34:07 GMT
• can-fite (nyse: canf) grants 24,000 stock options to its cso Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• can-fite (canf) grants 24,000 share options to ceo, cfo and coo Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• canf stock price, quote & chart | can fite biopharma ltd-adr (nysearca:canf) ChartMill Fri, 05 Jun 2026 07:00:00 GMT
• can-fite biopharma shareholders approve all proposals at 2026 annual meeting TipRanks Thu, 04 Jun 2026 07:00:00 GMT
• can-fite biopharma q4 2023 earnings: loss narrower than expected as pipeline advances - profit announcement newsline.com Thu, 04 Jun 2026 07:00:00 GMT
• can-fite biopharma (canf) shareholders approve five proposals at 2026 agm Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• can-fite (canf) reports pancreatic phase 2a data and ras pathway focus Stock Titan Tue, 02 Jun 2026 11:02:04 GMT
• Can-Fite Reports Positive Clinical Observation in Phase 2a GlobeNewswire Tue, 02 Jun 2026 07:00:00 GMT
• drug aiming at ras shows prolonged control in deadly pancreatic cancer Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• can-fite biopharma posts positive phase 2a signal for namodenoson in pancreatic cancer TipRanks Tue, 02 Jun 2026 07:00:00 GMT
• CANF Q4 2023 Earnings: Narrowed Loss Significantly Beats Estimates, Stock Slightly Down - EPS Surprise History dars.gov.et Sat, 30 May 2026 07:00:00 GMT
• can-fite biopharma adjourns 2026 shareholder meeting for lack of quorum The Globe and Mail Fri, 29 May 2026 22:00:00 GMT
• canf q4 2023 earnings: significant eps beat despite revenue absence - one-time loss impact newsline.com Fri, 29 May 2026 07:00:00 GMT
• canf technical analysis | trend, signals & chart patterns | can fite biopharma ltd-adr (nysearca:canf) ChartMill Fri, 29 May 2026 07:00:00 GMT
• can-fite biopharma adjourns 2026 shareholder meeting for lack of quorum TipRanks Thu, 28 May 2026 22:17:51 GMT
• canf q4 2023 earnings: narrower loss surprises amid pre-revenue stage - profitability analysis newsline.com Thu, 28 May 2026 07:00:00 GMT
• can-fite biopharma (canf) delays 2026 shareholder meeting after no quorum Stock Titan Thu, 28 May 2026 07:00:00 GMT
• can-fite biopharma (canf) slides 2.62% toward $3.18 support as selling pressure persists - high conviction picks newsline.com Thu, 28 May 2026 00:41:12 GMT
• can-fite biopharma (canf) slides 2.62% toward $3.18 support as selling pressure persists - pre-earnings momentum dars.gov.et Wed, 27 May 2026 07:00:00 GMT
• can-fite biopharma (canf) slips 3.2% as stock tests key support level - gamma exposure newsline.com Wed, 27 May 2026 07:00:00 GMT
• canf stock chart | can fite biopharma ltd-adr (nysearca:canf) ChartMill Tue, 26 May 2026 07:00:00 GMT
• can-fite biopharma (canf) faces continued pressure: support levels in focus - overnight profile newsline.com Mon, 25 May 2026 07:00:00 GMT
• canf q4 2023 earnings: eps surprise of 96% as biotech reports narrower-than-expected loss - guidance accuracy score newsline.com Sat, 23 May 2026 07:00:00 GMT
• can-fite biopharma q4 2023 earnings: significant eps surprise as biotech focuses on clinical pipeline - annual financial report thelegaladvocate.com Sat, 23 May 2026 07:00:00 GMT
• can-fite biopharma shares edge lower amid sector pressure, holds near support - late stage breakouts The Legal Advocate Fri, 22 May 2026 07:00:00 GMT
• canf q4 2023 earnings: narrower-than-expected loss signals operational progress - earnings revision downgrade newsline.com Fri, 22 May 2026 07:00:00 GMT
• canf q4 2023 earnings: surprise eps beat amid zero revenue; stock slides - core business growth newsline.com Fri, 22 May 2026 07:00:00 GMT
• can-fite biopharma (canf) edges lower as stock tests support near $3.21 - stop hunt The Legal Advocate Fri, 22 May 2026 07:00:00 GMT
• can-fite bio (canf) q4 2023 earnings: outperformance signals momentum - healthcare earnings report newsline.com Wed, 20 May 2026 07:00:00 GMT
• can-fite biopharma - depositary receipt (canf) price target decreased by 10.95% to 4.19 MSN Tue, 19 May 2026 22:17:01 GMT
• canf stock price, quote & chart | can fite biopharma ltd-adr (nysearca:canf) ChartMill Tue, 19 May 2026 07:00:00 GMT
• scientific publication of can-fite and vetbiolix validates piclidenoson’s potential in the multi-billion dollar canine osteoarthri... Sahm Tue, 19 May 2026 06:53:03 GMT
• Can Fite Biopharma stock rises on osteoarthritis study publication Investing.com Mon, 18 May 2026 07:00:00 GMT
• scientific publication of can-fite and vetbiolix validates piclidenoson’s potential in the multi-billion dollar canine osteoarthri... Yahoo Finance Mon, 18 May 2026 07:00:00 GMT
• can-fite and vetbiolix gain peer-reviewed validation for piclidenoson in canine osteoarthritis TipRanks Mon, 18 May 2026 07:00:00 GMT
• can-fite (canf) highlights $325m vetbiolix deal and new canine oa data Stock Titan Mon, 18 May 2026 07:00:00 GMT
• can-fite announces publication on canine osteoarthritis study Investing.com Mon, 18 May 2026 07:00:00 GMT
• pill eases arthritis pain in dogs in study, tied to $325m can-fite deal Stock Titan Mon, 18 May 2026 07:00:00 GMT
• can-fite biopharma raised to buy from hold by d. boral capital Moomoo Thu, 14 May 2026 11:04:18 GMT
• canf stock chart | can fite biopharma ltd-adr (nysearca:canf) ChartMill Thu, 14 May 2026 07:00:00 GMT
• canf upgraded by d. boral capital -- price target set at $7.00 GuruFocus Thu, 14 May 2026 03:44:34 GMT
Can-Fite BioPharma Ltd(NYSE MKT:CANF) 